{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:14:17Z","timestamp":1785197657436,"version":"3.55.0"},"reference-count":228,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:00:00Z","timestamp":1683072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Hair-loss diseases comprise heterogenous conditions with respective pathophysiology and clinicopathological characteristics. Major breakthroughs in hair follicle biology and immunology have led to the elucidation of etiopathogenesis of non-scarring alopecia (e.g., alopecia areata, AA) and cicatricial alopecia (e.g., lichen planopilaris, LPP). High-throughput genetic analyses revealed molecular mechanism underlying the disease susceptibility of hair loss conditions, such as androgenetic alopecia (AGA) and female pattern hair loss (FPHL). Hair loss attracted public interest during the COVID-19 pandemic. The knowledge of hair loss diseases is robustly expanding and thus requires timely updates. In this review, the diagnostic and measurement methodologies applied to hair loss diseases are updated. Of note, novel criteria and classification\/scoring systems published in the last decade are reviewed, highlighting their advantages over conventional ones. Emerging diagnostic techniques are itemized with clinical pearls enabling efficient utilization. Recent advances in understanding the etiopathogenesis and management for representative hair diseases, namely AGA, FPHL, AA, and major primary cicatricial alopecia, including LPP, are comprehensively summarized, focusing on causative factors, genetic predisposition, new disease entity, and novel therapeutic options. Lastly, the association between COVID-19 and hair loss is discussed to delineate telogen effluvium as the predominating pathomechanism accounting for this sequela.<\/jats:p>","DOI":"10.3390\/jcm12093259","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T01:33:36Z","timestamp":1683164016000},"page":"3259","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases"],"prefix":"10.3390","volume":"12","author":[{"given":"Misaki","family":"Kinoshita-Ise","sequence":"first","affiliation":[{"name":"Department of Dermatology, Kyorin University Faculty of Medicine, Tokyo 181-8611, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Fukuyama","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kyorin University Faculty of Medicine, Tokyo 181-8611, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2662-5717","authenticated-orcid":false,"given":"Manabu","family":"Ohyama","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kyorin University Faculty of Medicine, Tokyo 181-8611, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1346-8138.16207","article-title":"Alopecia areata: Current understanding of the pathophysiology and update on therapeutic approaches, featuring the Japanese Dermatological Association guidelines","volume":"49","author":"Fukuyama","year":"2022","journal-title":"J. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jdermsci.2021.01.007","article-title":"Telogen Effluvium\u2014A review of the science and current obstacles","volume":"101","author":"Wang","year":"2021","journal-title":"J Dermatol Sci"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/1346-8138.16252","article-title":"Primary cicatricial alopecia: Recent advances in evaluation and diagnosis based on trichoscopic and histopathological observation, including overlapping and specific features","volume":"49","author":"Uchiyama","year":"2022","journal-title":"J. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/bjd.20567","article-title":"Guidelines for clinical trials of frontal fibrosing alopecia: Consensus recommendations from the International FFA Cooperative Group (IFFACG)","volume":"185","author":"Olsen","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jaad.2019.12.056","article-title":"Fibrosing alopecia in a pattern distribution","volume":"85","author":"Griggs","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jaad.2006.12.029","article-title":"A new classification of pattern hair loss that is universal for men and women: Basic and specific (BASP) classification","volume":"57","author":"Lee","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/jdv.13455","article-title":"Towards a consensus on how to diagnose and quantify female pattern hair loss\u2014The \u2019Female Pattern Hair Loss Severity Index (FPHL-SI)\u2019","volume":"30","author":"Harries","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/ajd.12964","article-title":"The Trichoscopy Derived Sinclair Scale: Enhancing visual assessment through quantitative trichoscopy","volume":"60","author":"Kasprzak","year":"2019","journal-title":"Australas J. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/1346-8138.16233","article-title":"Update on trichoscopy: Integration of the terminology by systematic approach and a proposal of a diagnostic flowchart","volume":"49","author":"Sachdeva","year":"2022","journal-title":"J. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.jaad.2020.11.057","article-title":"Hair pull test: A clinical update for patients with Asian- and Afro-textured hair","volume":"85","author":"McDonald","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jaad.2016.10.002","article-title":"Hair pull test: Evidence-based update and revision of guidelines","volume":"76","author":"McDonald","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jdermsci.2021.04.008","article-title":"Ultra high-frequency ultrasound with seventy-MHz transducer in hair disorders: Development of a novel noninvasive diagnostic methodology","volume":"102","author":"Ohyama","year":"2021","journal-title":"J. Dermatol. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1111\/jdv.16304","article-title":"Optical coherence tomography in diagnosis of inflammatory scalp disorders","volume":"34","author":"Tsatalis","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jdermsci.2006.12.002","article-title":"Hair follicle bulge: A fascinating reservoir of epithelial stem cells","volume":"46","author":"Ohyama","year":"2007","journal-title":"J. Dermatol. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1523-1747.2003.12169.x","article-title":"Hair follicle stem cells","volume":"8","author":"Lavker","year":"2003","journal-title":"J. Investig. Derm. Symp. Proc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.molmed.2018.03.007","article-title":"Lichen Planopilaris and Frontal Fibrosing Alopecia as Model Epithelial Stem Cell Diseases","volume":"24","author":"Harries","year":"2018","journal-title":"Trends Mol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/j.1365-2133.2012.10877.x","article-title":"Investigation of the male pattern baldness major genetic susceptibility loci AR\/EDA2R and 20p11 in female pattern hair loss","volume":"166","author":"Redler","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2021.12.058","article-title":"The association between frontal fibrosing alopecia, sunscreen, and moisturizers: A systematic review and meta-analysis","volume":"87","author":"Maghfour","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1038\/ncomms6966","article-title":"Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci","volume":"6","author":"Betz","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jdin.2022.02.006","article-title":"Alopecia in patients with COVID-19: A systematic review and meta-analysis","volume":"7","author":"Nguyen","year":"2022","journal-title":"JAAD Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaad.2012.09.043","article-title":"Frontal fibrosing alopecia: A retrospective review of 19 patients seen at Duke University","volume":"68","author":"Ladizinski","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archderm.136.2.205","article-title":"Fibrosing alopecia in a pattern distribution: Patterned lichen planopilaris or androgenetic alopecia with a lichenoid tissue reaction pattern?","volume":"136","author":"Zinkernagel","year":"2000","journal-title":"Arch. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","article-title":"Alopecia areata investigational assessment guidelines--Part II. National Alopecia Areata Foundation","volume":"51","author":"Olsen","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jaad.2016.08.042","article-title":"SALT II: A new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss","volume":"75","author":"Olsen","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jaad.2021.08.043","article-title":"Development of the alopecia areata scale for clinical use: Results of an academic-industry collaborative effort","volume":"86","author":"King","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/jama.1993.03500080046030","article-title":"A case-control study of baldness in relation to myocardial infarction in men","volume":"269","author":"Lesko","year":"1993","journal-title":"JAMA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2133.1977.tb15179.x","article-title":"Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex","volume":"97","author":"Ludwig","year":"1977","journal-title":"Br. J. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0190-9622(99)70539-6","article-title":"The midline part: An important physical clue to the clinical diagnosis of androgenetic alopecia in women","volume":"40","author":"Olsen","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1046\/j.0007-0963.2003.05809.x","article-title":"Women who present with female pattern hair loss tend to underestimate the severity of their hair loss","volume":"150","author":"Biondo","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2133.2005.06218.x","article-title":"Treatment of female pattern hair loss with oral antiandrogens","volume":"152","author":"Sinclair","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jdermsci.2006.10.011","article-title":"Characteristic features of Japanese women\u2019s hair with aging and with progressing hair loss","volume":"45","author":"Tajima","year":"2007","journal-title":"J. Dermatol. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/ijt.ijt_80_17","article-title":"A New Classification of Early Female Pattern Hair Loss","volume":"10","author":"Kaneko","year":"2018","journal-title":"Int. J. Trichology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5021\/ad.2012.24.3.243","article-title":"Characteristics of androgenetic alopecia in asian","volume":"24","author":"Lee","year":"2012","journal-title":"Ann. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jaad.2009.08.054","article-title":"Hydroxychloroquine and lichen planopilaris: Efficacy and introduction of Lichen Planopilaris Activity Index scoring system","volume":"62","author":"Chiang","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/bjd.14445","article-title":"Frontal Fibrosing Alopecia Severity Index (FFASI): A validated scoring system for assessing frontal fibrosing alopecia","volume":"175","author":"Holmes","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jaad.2017.09.034","article-title":"Development and validation of the Frontal Fibrosing Alopecia Severity Score","volume":"78","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4103\/0974-7753.58553","article-title":"Hair evaluation methods: Merits and demerits","volume":"1","author":"Dhurat","year":"2009","journal-title":"Int. J. Trichology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1016\/j.jaad.2014.05.008","article-title":"Evaluation and diagnosis of the hair loss patient: Part I. History and clinical examination","volume":"71","author":"Mubki","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_39","first-page":"1236","article-title":"Telogen Effluvium With Dysesthesia (TED) Has Lower B12 Levels and May Respond to B12 Supplementation","volume":"17","author":"Daly","year":"2018","journal-title":"J. Drugs Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2010.10011.x","article-title":"S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents","volume":"164","author":"Blumeyer","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jaad.2018.04.032","article-title":"Vitamin D status in scarring and nonscarring alopecia","volume":"85","author":"Conic","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaad.2021.07.079","article-title":"The epidemiology, impact, and diagnosis of micronutrient nutritional dermatoses part 1: Zinc, selenium, copper, vitamin A, and vitamin C","volume":"86","author":"Nosewicz","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jaad.2021.06.900","article-title":"The epidemiology, impact, and diagnosis of micronutrient nutritional dermatoses. Part 2: B-complex vitamins","volume":"86","author":"Nosewicz","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"214","DOI":"10.5021\/ad.2014.26.2.214","article-title":"Dermoscopic approach to a small round to oval hairless patch on the scalp","volume":"26","author":"Shim","year":"2014","journal-title":"Ann. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1346-8138.2010.01119.x","article-title":"Trichoscopy for common hair loss diseases: Algorithmic method for diagnosis","volume":"38","author":"Inui","year":"2011","journal-title":"J. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4103\/0974-7753.130385","article-title":"Trichoscopy in alopecias: Diagnosis simplified","volume":"5","author":"Jain","year":"2013","journal-title":"Int. J. Trichology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/1346-8138.14283","article-title":"Trichoscopy of alopecia areata: An update","volume":"45","author":"Rakowska","year":"2018","journal-title":"J. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s13555-019-00350-1","article-title":"Trichoscopy of Tinea Capitis: A Systematic Review","volume":"10","author":"Rakowska","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/jdv.15974","article-title":"Trichoscopy of primary cicatricial alopecias: An updated review","volume":"34","author":"Mathur","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/ijd.15365","article-title":"Dermoscopy of discoid lupus erythematosus\u2014A systematic review of the literature","volume":"60","year":"2021","journal-title":"Int. J. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"adv00565","DOI":"10.2340\/00015555-3859","article-title":"Diagnostic Accuracy of Trichoscopy in Trichotillomania: A Systematic Review","volume":"101","author":"Kaczorowska","year":"2021","journal-title":"Acta Derm. Venereol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/1203475421999326","article-title":"Overview of Ultrasound Imaging Applications in Dermatology [Formula: See text]","volume":"25","author":"Almuhanna","year":"2021","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jdv.14571","article-title":"Optical coherence tomography for the investigation of frontal fibrosing alopecia","volume":"32","author":"Eber","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/lsm.23243","article-title":"Optical Coherence Tomography in the Evaluation of the Scalp and Hair: Common Features and Clinical Utility","volume":"53","author":"Ekelem","year":"2021","journal-title":"Lasers Surg. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/srt.12672","article-title":"Characteristic findings by phototrichogram in southern Chinese women with Female pattern hair loss","volume":"25","author":"Mai","year":"2019","journal-title":"Skin Res. Technol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1111\/jdv.17558","article-title":"Fluorescence advanced videodermoscopy: A new method of hairs and scalp evaluation. Comparison with trichoscopy","volume":"35","author":"Rossi","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e561","DOI":"10.1111\/jdv.18029","article-title":"Clinical, trichoscopic and in vivo reflectance confocal microscopy evaluation of alopecia areata in atopic dermatitis patients treated with dupilumab","volume":"36","author":"Napolitano","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/srt.12940","article-title":"Features of classic lichen planopilaris and frontal fibrosing alopecia in reflectance confocal microscopy: A preliminary study","volume":"27","author":"Kurzeja","year":"2021","journal-title":"Skin Res. Technol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0190-9622(96)90328-X","article-title":"Transverse scalp sections: A proposed method for laboratory processing","volume":"35","author":"Frishberg","year":"1996","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/archderm.143.2.268-a","article-title":"Scalp biopsy specimens: Transverse vs. vertical sections","volume":"143","author":"Garcia","year":"2007","journal-title":"Arch. Dermatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1524-4725.2012.02462.x","article-title":"Hair counts from normal scalp biopsy in Taiwan","volume":"38","author":"Ko","year":"2012","journal-title":"Dermatol. Surg."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1067\/mjd.2002.119558","article-title":"Hair counts from scalp biopsy specimens in Asians","volume":"46","author":"Lee","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1600-0560.2008.01149.x","article-title":"Hair counts in scalp biopsy of males and females with androgenetic alopecia compared with normal subjects","volume":"36","author":"Aslani","year":"2009","journal-title":"J. Cutan. Pathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1001\/archderm.135.6.656","article-title":"Hair density in African Americans","volume":"135","author":"Sperling","year":"1999","journal-title":"Arch. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0190-9622(93)70106-4","article-title":"Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia","volume":"28","author":"Whiting","year":"1993","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/1346-8138.14470","article-title":"Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version","volume":"45","author":"Manabe","year":"2018","journal-title":"J. Dermatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jaad.2003.11.073","article-title":"Pathogenesis of androgenetic alopecia","volume":"50","author":"Rebora","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"126ra134","DOI":"10.1126\/scitranslmed.3003122","article-title":"Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia","volume":"4","author":"Garza","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1365-2133.2012.10856.x","article-title":"Hair follicle stem cell differentiation is inhibited through cross-talk between Wnt\/\u03b2-catenin and androgen signalling in dermal papilla cells from patients with androgenetic alopecia","volume":"166","author":"Attorresi","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/exd.14536","article-title":"Observations that suggest a contribution of altered dermal papilla mitochondrial function to androgenetic alopecia","volume":"31","author":"Chew","year":"2022","journal-title":"Exp. Dermatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/ics.12286","article-title":"The impact of oxidative stress on hair","volume":"37","year":"2015","journal-title":"Int. J. Cosmet. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.1038\/s41598-019-43998-7","article-title":"Progressive expression of PPARGC1\u03b1 is associated with hair miniaturization in androgenetic alopecia","volume":"9","author":"Ho","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/1346-8138.15672","article-title":"Impairment of autophagy may be associated with follicular miniaturization in androgenetic alopecia by inducing premature catagen","volume":"48","author":"Liu","year":"2021","journal-title":"J. Dermatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2133.2010.09816.x","article-title":"Association of androgenetic alopecia with metabolic syndrome in men: A community-based survey","volume":"163","author":"Su","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"493","DOI":"10.4103\/idoj.IDOJ_334_19","article-title":"Female Pattern Hair Loss-An Update","volume":"11","author":"Bhat","year":"2020","journal-title":"Indian Derm. Online J."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijwd.2018.05.001","article-title":"Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review","volume":"4","author":"Fabbrocini","year":"2018","journal-title":"Int. J. Womens Dermatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1365-2133.2001.04289.x","article-title":"The prevalence and types of androgenetic alopecia in Korean men and women","volume":"145","author":"Paik","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jdermsci.2022.02.011","article-title":"Early onset female pattern hair loss: A case-control study for analyzing clinical features and genetic variants","volume":"106","author":"Ohn","year":"2022","journal-title":"J. Dermatol. Sci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaad.2004.04.008","article-title":"Evaluation and treatment of male and female pattern hair loss","volume":"52","author":"Olsen","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jdermsci.2017.04.002","article-title":"The ovariectomized mouse simulates the pathophysiology of postmenopausal female pattern hair loss","volume":"87","author":"Endo","year":"2017","journal-title":"J. Dermatol. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jdermsci.2018.04.001","article-title":"Reversal of the hair loss phenotype by modulating the estradiol-ANGPT2 axis in the mouse model of female pattern hair loss","volume":"91","author":"Endo","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1365-4362.2000.00612.x","article-title":"Androgenetic alopecia and microinflammation","volume":"39","author":"Michelet","year":"2000","journal-title":"Int. J. Dermatol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Ho, B.S., Ho, E.X.P., Chu, C.W., Ramasamy, S., Bigliardi-Qi, M., de Sessions, P.F., and Bigliardi, P.L. (2019). Microbiome in the hair follicle of androgenetic alopecia patients. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0216330"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jaad.2021.11.027","article-title":"The comparison of demographics and comorbidities of female pattern hair loss according to the clinical subtype and stage","volume":"87","author":"Engin","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/jvc2.53","article-title":"The state-of-the-art in the management of androgenetic alopecia: A review of new therapies and treatment algorithms","volume":"1","year":"2022","journal-title":"JEADV Clin. Pract."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1001\/jamadermatol.2021.5743","article-title":"Relative Efficacy of Minoxidil and the 5-\u03b1 Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis","volume":"158","author":"Gupta","year":"2022","journal-title":"JAMA Dermatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5021\/ad.22.027","article-title":"Long-Term Effectiveness and Safety of Dutasteride versus Finasteride in Patients with Male Androgenic Alopecia in South Korea: A Multicentre Chart Review Study","volume":"34","author":"Choi","year":"2022","journal-title":"Ann. Dermatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1067\/mjd.2002.124608","article-title":"Hair loss in women with hyperandrogenism: Four cases responding to finasteride","volume":"47","author":"Shum","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e12588","DOI":"10.1111\/dth.12588","article-title":"Clinical efficacy of oral administration of finasteride at a dose of 2.5 mg\/day in women with female pattern hair loss","volume":"31","author":"Won","year":"2018","journal-title":"Dermatol. Ther."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jaad.2006.05.007","article-title":"The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride","volume":"55","author":"Olsen","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_91","first-page":"155","article-title":"The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review","volume":"18","author":"Sung","year":"2019","journal-title":"J. Drugs Dermatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5414\/CP202467","article-title":"Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia","volume":"54","author":"Caserini","year":"2016","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jaad.2010.09.724","article-title":"A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women","volume":"65","author":"Hillmann","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-2133.1998.02115.x","article-title":"Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells","volume":"138","author":"Lachgar","year":"1998","journal-title":"Br. J. Dermatol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"472","DOI":"10.5114\/ada.2020.99947","article-title":"Sulfotransferase SULT1A1 activity in hair follicle, a prognostic marker of response to the minoxidil treatment in patients with androgenetic alopecia: A review","volume":"39","author":"Pietrauszka","year":"2022","journal-title":"Post\u0119py Dermatol. Alergol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e12688","DOI":"10.1111\/dth.12688","article-title":"Characterization of follicular minoxidil sulfotransferase activity in a cohort of pattern hair loss patients from the Indian Subcontinent","volume":"31","author":"Chitalia","year":"2018","journal-title":"Dermatol. Ther."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaad.2020.06.1009","article-title":"Oral minoxidil treatment for hair loss: A review of efficacy and safety","volume":"84","author":"Randolph","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/ijd.13838","article-title":"Female pattern hair loss: A pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone","volume":"57","author":"Sinclair","year":"2018","journal-title":"Int. J. Dermatol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jaad.2020.07.006","article-title":"Evaluation of platelet-rich plasma as a treatment for androgenetic alopecia: A randomized controlled trial","volume":"83","author":"Shapiro","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/09546634.2020.1770171","article-title":"Platelet-rich plasma as a therapy for androgenic alopecia: A systematic review and meta-analysis","volume":"33","author":"Evans","year":"2022","journal-title":"J. Dermatol. Treat."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/ijt.ijt_50_19","article-title":"Combination therapy with platelet-rich plasma and minoxidil leads to better clinical results than monotherapy with these methods in men with androgenetic alopecia","volume":"14","author":"Elena","year":"2022","journal-title":"Int. J. Trichology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/DSS.0000000000001198","article-title":"Platelet-Rich Plasma in Combination With 5% Minoxidil Topical Solution and 1 mg Oral Finasteride for the Treatment of Androgenetic Alopecia: A Randomized Placebo-Controlled, Double-Blind, Half-Head Study","volume":"44","author":"Alves","year":"2018","journal-title":"Dermatol. Surg."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Gabbard, R.D., Hoopes, R.R., and Kemp, M.G. (2020). Spironolactone and XPB: An Old Drug with a New Molecular Target. Biomolecules, 10.","DOI":"10.3390\/biom10050756"},{"key":"ref_104","first-page":"e15321","article-title":"Spironolactone in dermatology","volume":"35","author":"Cazarin","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_105","first-page":"CD007628","article-title":"Interventions for female pattern hair loss","volume":"2016","author":"Fedorowicz","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jaad.2020.03.087","article-title":"Spironolactone for treatment of female pattern hair loss","volume":"83","author":"Burns","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_107","first-page":"e14678","article-title":"A novel topical combination of minoxidil and spironolactone for androgenetic alopecia: Clinical, histopathological, and physicochemical study","volume":"34","author":"Aly","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1111\/jocd.15328","article-title":"Dermoscopic evaluation of the efficacy of combination of topical spironolactone 5% and minoxidil 5% solutions in the treatment of androgenetic alopecia: A cross sectional-comparative study","volume":"21","author":"Ammar","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jaad.2020.05.081","article-title":"Spironolactone use does not increase the risk of female breast cancer recurrence: A retrospective analysis","volume":"83","author":"Wei","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1365-2133.2002.04798.x","article-title":"Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: A controlled, 12-month randomized trial","volume":"146","author":"Vexiau","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.jaad.2018.08.061","article-title":"Androgens in women: Hormone-modulating therapies for skin disease","volume":"80","author":"Azarchi","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e2020039","DOI":"10.5826\/dpc.1002a39","article-title":"Efficacy of Topical Finasteride 0.5% vs 17alpha-Estradiol 0.05% in the Treatment of Postmenopausal Female Pattern Hair Loss: A Retrospective, Single-Blind Study of 119 Patients","volume":"10","author":"Rossi","year":"2020","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000509001","article-title":"Examining the Safety and Efficacy of Low-Level Laser Therapy for Male and Female Pattern Hair Loss: A Review of the Literature","volume":"6","author":"Egger","year":"2020","journal-title":"Ski. Appendage Disord."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4103\/JCAS.JCAS_218_20","article-title":"Role of Low-Level Light Therapy (LLLT) in Androgenetic Alopecia","volume":"14","author":"Pillai","year":"2021","journal-title":"J. Cutan. Aesthetic Surg."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/j.1468-3083.2011.04183.x","article-title":"The effect of a 1550 nm fractional erbium-glass laser in female pattern hair loss","volume":"25","author":"Lee","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s10103-018-02699-9","article-title":"Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: A 24-week, randomized, double-blind, sham device-controlled trial","volume":"34","author":"Suchonwanit","year":"2019","journal-title":"Lasers Med. Sci."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/09546634.2017.1341610","article-title":"A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia","volume":"29","author":"Rossi","year":"2018","journal-title":"J. Dermatolog. Treat."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1111\/jocd.15309","article-title":"Topical cetirizine for treating androgenetic alopecia: A systematic review","volume":"21","author":"Chen","year":"2022","journal-title":"J. Cosmet Dermatol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jaad.2020.02.033","article-title":"Autologous cell-based therapy for male and female pattern hair loss using dermal sheath cup cells: A randomized placebo-controlled double-blinded dose-finding clinical study","volume":"83","author":"Tsuboi","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1159\/000017954","article-title":"Ketoconazole shampoo: Effect of long-term use in androgenic alopecia","volume":"196","author":"Cauwenbergh","year":"1998","journal-title":"Dermatology"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/0974-7753.111199","article-title":"Topical melatonin for treatment of androgenetic alopecia","volume":"4","author":"Fischer","year":"2012","journal-title":"Int. J. Trichology"},{"key":"ref_122","first-page":"52","article-title":"An Open-Label Evaluator Blinded Study of the Efficacy and Safety of a New Nutritional Supplement in Androgenetic Alopecia: A Pilot Study","volume":"10","author":"Nichols","year":"2017","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"ref_123","first-page":"e14267","article-title":"Micro needling: A novel therapeutic approach for androgenetic alopecia, A Review of Literature","volume":"33","author":"Fabbrocini","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_124","first-page":"1","article-title":"Promising therapies for treating and\/or preventing androgenic alopecia","volume":"17","author":"McElwee","year":"2012","journal-title":"Ski. Ther. Lett."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMra1103442","article-title":"Alopecia areata","volume":"366","author":"Gilhar","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_126","first-page":"609","article-title":"Italian Guidelines in diagnosis and treatment of alopecia areata","volume":"154","author":"Rossi","year":"2019","journal-title":"G. Ital. Di Dermatol. E Venereol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/jid.2013.464","article-title":"Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990\u20132009","volume":"134","author":"Mirzoyev","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4065\/70.7.628","article-title":"Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989","volume":"70","author":"Safavi","year":"1995","journal-title":"Mayo Clin. Proc."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/1346-8138.16606","article-title":"Prevalence of alopecia areata in Japan: Estimates from a nationally representative sample","volume":"50","author":"Aranishi","year":"2022","journal-title":"J. Dermatol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0002-9440(10)63151-3","article-title":"Collapse and restoration of MHC class-I-dependent immune privilege: Exploiting the human hair follicle as a model","volume":"164","author":"Ito","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/sj.jid.5701183","article-title":"Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack","volume":"128","author":"Ito","year":"2008","journal-title":"J. Investig. Dermatol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1056\/NEJMoa2110343","article-title":"Two Phase 3 Trials of Baricitinib for Alopecia Areata","volume":"386","author":"King","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/bjd.16808","article-title":"Alopecia areata: A review of disease pathogenesis","volume":"179","author":"Rajabi","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/jdv.14775","article-title":"Role of T helper 17 cells and T regulatory cells in alopecia areata: Comparison of lesion and serum cytokine between controls and patients","volume":"32","author":"Loh","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/exd.12918","article-title":"Biomarkers of alopecia areata disease activity and response to corticosteroid treatment","volume":"25","author":"Gulati","year":"2016","journal-title":"Exp. Dermatol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaci.2015.06.032","article-title":"Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17\/TH22 skewing","volume":"136","author":"Ungar","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"979876","DOI":"10.3389\/fnut.2022.979876","article-title":"The gut microbiome and Alopecia areata: Implications for early diagnostic biomarkers and novel therapies","volume":"9","author":"Kang","year":"2022","journal-title":"Front. Nutr."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.abd.2020.05.006","article-title":"Consensus on the treatment of alopecia areata\u2014Brazilian Society of Dermatology","volume":"95","author":"Ramos","year":"2020","journal-title":"An. Bras. De Dermatol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/ajd.12941","article-title":"Treatment of alopecia areata: An Australian expert consensus statement","volume":"60","author":"Cranwell","year":"2019","journal-title":"Australas. J. Dermatol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1365-2133.2012.10955.x","article-title":"British Association of Dermatologists\u2019 guidelines for the management of alopecia areata 2012","volume":"166","author":"Messenger","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.jaad.2020.09.028","article-title":"The Alopecia Areata Consensus of Experts (ACE) study part II: Results of an international expert opinion on diagnosis and laboratory evaluation for alopecia areata","volume":"84","author":"Meah","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/1346-8138.15306","article-title":"Elucidation of demographic, clinical and trichoscopic features for early diagnosis of self-healing acute diffuse and total alopecia","volume":"47","author":"Fukuyama","year":"2020","journal-title":"J. Dermatol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"955035","DOI":"10.3389\/fimmu.2022.955035","article-title":"An overview of JAK\/STAT pathways and JAK inhibition in alopecia areata","volume":"13","author":"Lensing","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_145","first-page":"e89776","article-title":"Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata","volume":"1","author":"Ko","year":"2016","journal-title":"JCI Insight"},{"key":"ref_146","first-page":"e89790","article-title":"Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata","volume":"1","author":"Jabbari","year":"2016","journal-title":"JCI Insight"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jaad.2021.03.050","article-title":"A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results","volume":"85","author":"King","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jid.2018.01.032","article-title":"An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis","volume":"138","author":"Jabbari","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00403-022-02336-0","article-title":"A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata","volume":"315","author":"Mikhaylov","year":"2023","journal-title":"Arch. Dermatol. Res."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jaad.2022.03.045","article-title":"Phase 2 randomized, dose-ranging trial of CTP-543, a selective Janus Kinase inhibitor, in moderate-to-severe alopecia areata","volume":"87","author":"King","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/jdv.15937","article-title":"Benefit and risk profile of tofacitinib for the treatment of alopecia areata: A systemic review and meta-analysis","volume":"34","author":"Guo","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jaad.2021.02.071","article-title":"Alopecia areata flare patterns in children and young adults while on systemic tofacitinib","volume":"86","author":"McKenzie","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/bjd.18976","article-title":"The effectiveness of dupilumab in patients with alopecia areata who have atopic dermatitis: A case series of seven patients","volume":"183","author":"Harada","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2340\/00015555-3183","article-title":"Dupilumab Improved Alopecia Areata in a Patient with Atopic Dermatitis: A Case Report","volume":"99","author":"Uchida","year":"2019","journal-title":"Acta Derm. Venereol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.alit.2020.02.009","article-title":"Dupilumab therapy rapidly improved alopecia areata associated with trichotillomania in an atopic dermatitis patient","volume":"69","author":"Ushida","year":"2020","journal-title":"Allergol. Int."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/all.15071","article-title":"Phase 2a randomized clinical trial of dupilumab (anti-IL-4R\u03b1) for alopecia areata patients","volume":"77","author":"Bares","year":"2022","journal-title":"Allergy"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1684\/ejd.2014.2380","article-title":"Involvement of Fc\u025bR1\u03b1 immunopositive cells in alopecia areata with atopic dermatitis and a high titer of serum immunoglobulin E","volume":"24","author":"Yoshimasu","year":"2014","journal-title":"Eur. J. Dermatol."},{"key":"ref_158","first-page":"1047","article-title":"Scalp Biomarkers During Dupilumab Treatment Support Th2 Pathway Pathogenicity in Alopecia Areata","volume":"78","author":"Pavel","year":"2022","journal-title":"Allergy"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jdcr.2019.03.019","article-title":"Alopecia areata in 2 patients treated with dupilumab: New onset and worsening","volume":"5","author":"Chung","year":"2019","journal-title":"JAAD Case Rep."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Kageyama, R., Ito, T., Hanai, S., Morishita, N., Nakazawa, S., Fujiyama, T., Honda, T., and Tokura, Y. (2021). Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052618"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jisp.2020.05.002","article-title":"Platelet-Rich Plasma in the Treatment of Alopecia Areata: A Review","volume":"20","author":"Almohanna","year":"2020","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Meznerics, F.A., Ill\u00e9s, K., Dembrovszky, F., Feh\u00e9rv\u00e1ri, P., Kem\u00e9ny, L.V., Kov\u00e1cs, K.D., Wikonk\u00e1l, N.M., Csupor, D., Hegyi, P., and B\u00e1nv\u00f6lgyi, A. (2022). Platelet-Rich Plasma in Alopecia Areata-A Steroid-Free Treatment Modality: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Biomedicines, 10.","DOI":"10.3390\/biomedicines10081829"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"920","DOI":"10.4103\/idoj.IDOJ_6_20","article-title":"A Comparative Study of Therapeutic Response to Intralesional Injections of Platelet-Rich Plasma Versus Triamcinolone Acetonide in Alopecia Areata","volume":"11","author":"Balakrishnan","year":"2020","journal-title":"Indian Derm. Online J."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"e14388","DOI":"10.1111\/dth.14388","article-title":"A randomized, placebo and active controlled, split scalp study to evaluate the efficacy of platelet-rich plasma in patchy alopecia areata of the scalp","volume":"33","author":"Hegde","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/JCAS.JCAS_16_19","article-title":"Comparative Evaluation of Therapeutic Efficacy of Intralesional Injection of Triamcinolone Acetonide versus Intralesional Autologous Platelet-rich Plasma Injection in Alopecia Areata","volume":"13","author":"Kapoor","year":"2020","journal-title":"J. Cutan. Aesthetic Surg."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jisp.2017.10.013","article-title":"Treatment of Alopecia Areata with Simvastatin\/Ezetimibe","volume":"19","author":"Cervantes","year":"2018","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jaad.2020.03.102","article-title":"Putative therapeutic mechanisms of simvastatin in the treatment of alopecia areata","volume":"84","author":"Shin","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"e1013","DOI":"10.1111\/jdv.18423","article-title":"Downregulation of pathogenic MICA-NKG2D interactions as a novel strategy in alopecia areata management: A new rationale for adjunct statin therapy?","volume":"36","author":"Gherardini","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jaad.2014.11.006","article-title":"Treatment of alopecia areata with simvastatin\/ezetimibe","volume":"72","author":"Lattouf","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/jamadermatol.2014.1544","article-title":"Alopecia universalis successfully treated with adalimumab","volume":"150","author":"Gorcey","year":"2014","journal-title":"JAMA Dermatol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.0022-202X.2005.10130_6.x","article-title":"Treatment of alopecia areata with anti-interferon-gamma antibodies","volume":"10","author":"Skurkovich","year":"2005","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2007.10.645","article-title":"Subcutaneous efalizumab is not effective in the treatment of alopecia areata","volume":"58","author":"Price","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaad.2005.03.039","article-title":"Etanercept does not effectively treat moderate to severe alopecia areata: An open-label study","volume":"52","author":"Strober","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00403-018-1876-y","article-title":"A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata","volume":"311","author":"Mikhaylov","year":"2019","journal-title":"Arch. Dermatol. Res."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000446119","article-title":"Telogen Effluvium: Is There a Need for a New Classification?","volume":"2","year":"2016","journal-title":"Ski. Appendage Disord."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/archderm.1961.01580080005001","article-title":"Pathologic dynamics of human hair loss. I. Telogen effuvium","volume":"83","author":"Kligman","year":"1961","journal-title":"Arch. Dermatol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4103\/0378-6323.116731","article-title":"Telogen effluvium","volume":"79","author":"Grover","year":"2013","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_178","first-page":"WE01","article-title":"Telogen Effluvium: A Review","volume":"9","author":"Malkud","year":"2015","journal-title":"J. Clin. Diagn Res."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/archderm.1993.01680240096017","article-title":"Telogen effluvium. New concepts and review","volume":"129","author":"Headington","year":"1993","journal-title":"Arch. Dermatol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000446118","article-title":"Proposing a Simpler Classification of Telogen Effluvium","volume":"2","author":"Rebora","year":"2016","journal-title":"Ski. Appendage Disord."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0733-8635(05)70398-3","article-title":"Chronic telogen effluvium","volume":"14","author":"Whiting","year":"1996","journal-title":"Dermatol. Clin."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2147\/CCID.S227232","article-title":"Vitamin D Receptor Gene Polymorphism In Chronic Telogen Effluvium; A Case-Control Study","volume":"12","author":"Seleit","year":"2019","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00003246-198801000-00020","article-title":"Postfebrile telogen effluvium in critically ill patients","volume":"16","author":"Bernstein","year":"1988","journal-title":"Crit. Care Med."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/1346-8138.16475","article-title":"Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight into the pathophysiology with implication for better management","volume":"49","author":"Ohyama","year":"2022","journal-title":"J. Dermatol."},{"key":"ref_185","first-page":"66","article-title":"Acute telogen effluvium due to Dengue fever mimicking androgenetic alopecia","volume":"158","author":"Starace","year":"2023","journal-title":"Ital. J. Dermatol. Venerol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1610-0387.2010.07261.x","article-title":"Systematic approach to hair loss in women","volume":"8","year":"2010","journal-title":"J. Der Dtsch. Dermatol. Ges."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/S0140-6736(22)00941-2","article-title":"Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2","volume":"399","author":"Antonelli","year":"2022","journal-title":"Lancet"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1111\/jdv.16953","article-title":"Anti-androgens may protect against severe COVID-19 outcomes: Results from a prospective cohort study of 77 hospitalized men","volume":"35","author":"Goren","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.annonc.2020.04.479","article-title":"Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: A population-based study (N = 4532)","volume":"31","author":"Montopoli","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"758069","DOI":"10.3389\/fmed.2021.758069","article-title":"Lack of Evidence of COVID-19 Being a Risk Factor of Alopecia Areata: Results of a National Cohort Study in South Korea","volume":"8","author":"Kim","year":"2021","journal-title":"Front. Med."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"e6039","DOI":"10.1002\/ccr3.6039","article-title":"COVID-19 vaccination and alopecia areata: A case report and literature review","volume":"10","author":"Ganjei","year":"2022","journal-title":"Clin. Case Rep."},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Michelini, S., Caro, G., Di Fraia, M., Fortuna, M., Magri, F., Gomes, V.V., Grieco, T., Carlesimo, M., Rossi, A., and Pellacani, G. (2023). Telogen effluvium in SARS-CoV-2 infection: Histological aspects. J. Eur. Acad. Dermatol. Venereol., in press.","DOI":"10.1111\/jdv.19015"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"100113","DOI":"10.1016\/j.xjidi.2022.100113","article-title":"Frontiers in Lichen Planopilaris and Frontal Fibrosing Alopecia Research: Pathobiology Progress and Translational Horizons","volume":"2","author":"Senna","year":"2022","journal-title":"JID Innov."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/bjd.18854","article-title":"Profiling the human hair follicle immune system in lichen planopilaris and frontal fibrosing alopecia: Can macrophage polarization differentiate these two conditions microscopically?","volume":"183","author":"Harries","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"pgac111","DOI":"10.1093\/pnasnexus\/pgac111","article-title":"Primary cicatricial alopecias are characterized by dysregulation of shared gene expression pathways","volume":"1","author":"Wang","year":"2022","journal-title":"PNAS Nexus"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2340\/00015555-1884","article-title":"Lichen planopilaris is associated with HLA DRB1*11 and DQB1*03 alleles","volume":"95","author":"Pavlovsky","year":"2015","journal-title":"Acta Derm. Venereol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/s41467-019-09117-w","article-title":"Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02","volume":"10","author":"Tziotzios","year":"2019","journal-title":"Nat Commun"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.18295\/squmj.2021.21.02.025","article-title":"Familial Frontal Fibrosing Alopecia: Report of a case and systematic review of the literature","volume":"21","year":"2021","journal-title":"Sultan Qaboos Univ. Med. J."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2133.2012.11101.x","article-title":"Familial frontal fibrosing alopecia","volume":"168","author":"Dlova","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jaad.2016.05.038","article-title":"Prevalence of hormonal and endocrine dysfunction in patients with lichen planopilaris (LPP): A retrospective data analysis of 168 patients","volume":"76","author":"Ranasinghe","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/1346-8138.16155","article-title":"Distinctive age distribution and hair loss pattern putatively highlighting uniqueness of Japanese cases of fibrosing alopecia in a pattern distribution","volume":"49","author":"Fukuyama","year":"2022","journal-title":"J. Dermatol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1056\/NEJMoa1816614","article-title":"Variant PADI3 in Central Centrifugal Cicatricial Alopecia","volume":"380","author":"Malki","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000479798","article-title":"Cicatricial Alopecia in Identical Twin Lumbee Native American Women","volume":"4","author":"Strowd","year":"2018","journal-title":"Ski. Appendage Disord."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archdermatol.2011.66","article-title":"Medical and environmental risk factors for the development of central centrifugal cicatricial alopecia: A population study","volume":"147","author":"Kyei","year":"2011","journal-title":"Arch. Dermatol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/jamadermatol.2017.5163","article-title":"Association of Uterine Leiomyomas With Central Centrifugal Cicatricial Alopecia","volume":"154","author":"Dina","year":"2018","journal-title":"JAMA Dermatol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"100060","DOI":"10.1016\/j.xjidi.2021.100060","article-title":"Presence of Uterine Leiomyomas Has No Significant Impact on Gene Expression Profile in the Scalp of Patients with Central Centrifugal Cicatricial Alopecia","volume":"2","author":"Jamerson","year":"2022","journal-title":"JID Innov."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1067\/mjd.2003.68","article-title":"Summary of North American Hair Research Society (NAHRS)-sponsored Workshop on Cicatricial Alopecia, Duke University Medical Center, February 10 and 11, 2001","volume":"48","author":"Olsen","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/ced.13989","article-title":"Folliculitis decalvans and lichen planopilaris phenotypic spectrum: A case series of biphasic clinical presentation and theories on pathogenesis","volume":"45","author":"Yip","year":"2020","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/DAD.0000000000001595","article-title":"Folliculitis Decalvans and Lichen Planopilaris Phenotypic Spectrum-A Series of 7 New Cases With Focus on Histopathology","volume":"42","author":"Egger","year":"2020","journal-title":"Am. J. Dermatopathol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/DAD.0000000000001758","article-title":"It has the Erythema of a Lichen Planopilaris, it has the Hyperkeratosis of a Lichen Planopilaris, but it is Not a Lichen Planopilaris: About the \"Lichen Planopilaris-Like\" Form of Folliculitis Decalvans","volume":"43","author":"Matard","year":"2021","journal-title":"Am. J. Dermatopathol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/jocd.15476","article-title":"The burden of gout in acne keloidalis nuchae-Insights from a population-based study","volume":"22","author":"Shavit","year":"2023","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2147\/CCID.S369243","article-title":"Acne Keloidalis Nuchae is Associated with Cutis Verticis Gyrata","volume":"15","author":"Umar","year":"2022","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1007\/s10067-022-06128-9","article-title":"Dissecting cellulitis of the scalp associated with peripheral and axial spondyloarthritis: Report of a case and review of the literature","volume":"41","author":"Jun","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/09546634.2019.1642441","article-title":"Approach to treatment of refractory dissecting cellulitis of the scalp: A systematic review","volume":"32","author":"Thomas","year":"2021","journal-title":"J. Dermatolog. Treat."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jaad.2022.02.044","article-title":"Refractory folliculitis decalvans treated with adalimumab: A case series of 23 patients","volume":"87","author":"Iorizzo","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jaad.2018.07.050","article-title":"Updates in therapeutics for folliculitis decalvans: A systematic review with evidence-based analysis","volume":"80","author":"Rambhia","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jaad.2014.10.036","article-title":"The use of oral pioglitazone in the treatment of lichen planopilaris","volume":"72","author":"Mesinkovska","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/archdermatol.2009.283","article-title":"Lichen planopilaris treated with a peroxisome proliferator-activated receptor gamma agonist","volume":"145","author":"Mirmirani","year":"2009","journal-title":"Arch. Dermatol."},{"key":"ref_220","first-page":"1276","article-title":"Response of Lichen Planopilaris to Pioglitazone Hydrochloride","volume":"18","author":"Peterson","year":"2019","journal-title":"J. Drugs Dermatol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jaad.2013.04.066","article-title":"Lichen planopilaris treated by the peroxisome proliferator activated receptor-\u03b3 agonist pioglitazone: Lack of lasting improvement or cure in the majority of patients","volume":"69","author":"Spring","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"e15868","DOI":"10.1111\/dth.15868","article-title":"Efficacy and safety of oral pioglitazone in the management of lichen planopilaris in comparison with clobetasol: A randomized clinical trial","volume":"35","author":"Lajevardi","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"e12656","DOI":"10.1111\/dth.12656","article-title":"Tofacitinib for the treatment of lichen planopilaris: A case series","volume":"31","author":"Yang","year":"2018","journal-title":"Dermatol. Ther."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.jaad.2020.05.104","article-title":"Tofacitinib in the treatment of lichen planopilaris: A retrospective review","volume":"83","author":"Plante","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jaad.2022.02.027","article-title":"Treatment of lichen planopilaris with baricitinib: A retrospective study","volume":"87","author":"Moussa","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"eaav7561","DOI":"10.1126\/scitranslmed.aav7561","article-title":"IFN-\u03b3 enhances cell-mediated cytotoxicity against keratinocytes via JAK2\/STAT1 in lichen planus","volume":"11","author":"Shao","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/ced\/llad036","article-title":"Treatment of dissecting cellulitis of the scalp with tumor necrosis factor inhibitors: A retrospective multicenter study","volume":"48","author":"Alzahrani","year":"2023","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.12788\/j.sder.2016.033","article-title":"Update on TNF Inhibitors in Dermatology","volume":"35","author":"Sobell","year":"2016","journal-title":"Semin. Cutan. Med. Surg."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/9\/3259\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:28:40Z","timestamp":1760124520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/9\/3259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,3]]},"references-count":228,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["jcm12093259"],"URL":"https:\/\/doi.org\/10.3390\/jcm12093259","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,3]]}}}